Ankuran Ivf Centre Profile
Key Indicators
- Authorised Capital ₹ 1.35 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.35 Cr
as on 17-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.00 Cr
as on 17-11-2024
- Revenue 979.79%
(FY 2023)
- Profit 268.22%
(FY 2023)
- Ebitda 3141.38%
(FY 2023)
- Net Worth 118.93%
(FY 2023)
- Total Assets 28.09%
(FY 2023)
About Ankuran Ivf Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.35 Cr and a paid-up capital of Rs 1.35 Cr.
The company currently has active open charges totaling ₹12.00 Cr.
Basab Mukherjee, Dibyendu Banerjee, and Basudeb Mukherjee serve as directors at the Company.
- CIN/LLPIN
U74999WB2020PTC240309
- Company No.
240309
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ankuran Ivf Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Basudeb Mukherjee  | Director | 07-Oct-2020 | Current |
| Basab Mukherjee | Director | 07-Oct-2020 | Current |
| Dibyendu Banerjee | Director | 07-Oct-2020 | Current |
Financial Performance of Ankuran Ivf Centre.
Ankuran Ivf Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 979.79% increase. The company also saw a substantial improvement in profitability, with a 268.22% increase in profit. The company's net worth Soared by an impressive increase of 118.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ankuran Ivf Centre?
Unlock access to Ankuran Ivf Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
B. D. Resources Pvt. Ltd.Active 30 years 6 daysBasab Mukherjee and Basudeb Mukherjee are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Mar 2024 | ₹6.00 Cr | Open |
Canara Bank Creation Date: 07 Sep 2021 | ₹6.00 Cr | Open |
How Many Employees Work at Ankuran Ivf Centre?
Ankuran Ivf Centre has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ankuran Ivf Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ankuran Ivf Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
